Watch Video—Nicholas Jacobson, an associate professor ofbiomedical data science and psychiatry, and the Therabot platform developed at Dartmouth are featured in a story about  young people using AI therapy chatbots. “I think one of the things that folks often don’t consider when they think about what our current care system is that most folks are not accessing a human already,” Jacobson said.

Read article—Amber Barnato, a professor of medicine, testified Monday at an FDA public hearing on psychedelic therapies, pointing to evidence that psilocybin-assisted treatment can produce durable reductions in depression, anxiety and demoralization among patients facing life-threatening illness, but that more research is required.

Read article—Shane Chapman, a professor of dermatology, is featured discussing FDA approval of a nonsurgical photodynamic therapy option for superficial basal cell carcinoma. “I see this as a meaningful expansion in the use of this treatment,” Chapman said.

Read article—Features a study led by Lynn Fiellin, a professor of biomedical data science and medicine, and postdoctoral research fellow Caroline Barry showing that PlaySmart, a digital behavioral health game developed in the Fiellin lab, reduced depressive symptoms among teens and improved attitudes toward seeking mental health care. “The key takeaway for clinicians and schools is that prevention does not have to wait until an adolescent is in crisis,” Barry said. “Digital tools like PlaySmart may provide another way to engage young people earlier and in a format that feels familiar and interactive.”

Read article—In an opinion piece, Miriam Voran, an assistant professor of psychology, offers guidance for parents on helping children navigate political instability, emphasizing age-appropriate conversations, emotional regulation, and independent thinking. “Stand for reality, but don’t rush your children out of childhood. Remember that civic education fits the goal of keeping up with your child’s maturing interests,” Voran writes. “Educate your children about the broader world.”

Read article—Angelo Volandes, senior associate dean for clinical and translational research at Geisel, and Nathan Goldstein, a professor of geriatrics, are featured in a story about a new federally funded Dartmouth Health and Geisel research program to study healthcare access for older adults in rural communities.

Read article—Features an international study led by Dartmouth researchers at Geisel and Dartmouth Health identifying a potential transfusion risk for patients with alpha-gal syndrome, particularly type O patients receiving B or AB plasma or platelets.

Read article—A report authored by Jared Rhodes, a professor of health policy, ranks New Hampshire sixth nationally for health care freedom. The report credits reforms to professional licensing and pharmacy scope of practice, along with adoption of Right to Try legislation, with helping the state rise in the rankings.

Read article—Anne Hoen, a professor of epidemiology, is featured in coverage of a Dartmouth study finding that some patients with type O blood and alpha-gal antibodies can have severe allergic reactions to certain plasma or platelet transfusions. “Even if it’s an abundance of caution, it could save the patient’s life,” Hoen said.

Read article—Features research led by James Sargent, a professor of community and family medicine, finding that greater exposure to alcohol marketing is associated with increased drinking-related outcomes among children and adolescents. The authors call for better measures of cumulative marketing exposure, particularly across digital and social media.